SUMATRIPTAN (Sandoz Inc)


Welcome to the PulseAid listing for the SUMATRIPTAN drug offered from Sandoz Inc. This Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: sumatriptan
SUBSTANCE NAME: SUMATRIPTAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
ROUTE: NASAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-09-11
END MARKETING DATE: 0000-00-00


SUMATRIPTAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSUMATRIPTAN from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/100uL)
START MARKETING DATE: 2008-09-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-6523_8610b426-8a9c-411f-97ae-37bd91bf260c
PRODUCT NDC: 0781-6523
APPLICATION NUMBER: NDA020626

Other SUMATRIPTAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline LLCIMITREX
Lannett Company, Inc.Sumatriptan
Physicians Total Care, Inc.SUMATRIPTAN
Sandoz IncSUMATRIPTAN